Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

1.72
Delayed Data
As of Nov 22
 -0.02 / -1.15%
Today’s Change
0.52
Today|||52-Week Range
2.95
-18.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues85.0K341.0K133.0K609.0K
 
 
 
 
 
Depreciation And Amortization324.0K200.0K213.0K44.0K
 
 
 
 
 
 
Operating ExpensesGross Income-239.0K141.0K----
 
 
 
General Expenses12.0M24.8M26.3M26.4M
 
 
 
 
 
Research And Development3.5M14.9M16.0M16.1M
 
 
 
 
 
Total Operating Expenses12.3M25.0M26.5M26.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.3M-24.7M-26.3M-25.9M
 
 
 
 
 
Extraordinary Credit15.0K--0.000.00
 
 
Extraordinary Charge-3.1M--0.000.00
 
 
Interest Expense On Debt193.0K12.0K502.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M-24.6M-26.7M-26.9M
 
 
 
 
 
Discontinued Operations-1.9M50.0K227.0K0.00
 
 
 
 
Extraordinary Items-86.0K1.1M0.000.00
 
 
 
Net Income-17.4M-24.6M-26.5M-26.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.1M17.5M20.1M22.0M
 
 
 
 
 
Shares To Calculate EPS Diluted6.1M17.5M20.1M22.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.85-$1.34-$1.32-$1.22
 
 
 
 
 
EPS Diluted-$2.84-$1.40-$1.32-$1.22